세계의 의료용 가스 및 기기 시장 : 유형별, 의료용 가스 기기별, 용도별, 최종사용자별 예측(-2029년)

The medical gas and equipment market is projected to reach USD 26.44 billion by 2029 from USD 19.90 billion in 2024, at a CAGR of 5.8% during the forecast period. The medical gas and equipment market has had strong growth due to a number of factors such as the rising incidences of chronic respiratory diseases like chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and bronchiectasis. Moreover, the initiatives to develop healthcare infrastructure in underdeveloped regions demand more medical gases and related equipments. Additionally, the growing trend of home healthcare services has also played a major role in the market's growth, due to the availability of portable oxygen systems.

"By type, medical gases segment is expected to have the largest market share in the medical gas and equipment market."

Based on the type, the medical gases segment is expected to dominate the the medical gas and equipment market due to several factors. Medical gases such as oxygen, nitrous oxide, carbon dioxide and medical air are necessary for different medical procedures including anesthesia, respiratory therapies and surgical interventions. The high number of people suffering from chronic diseases like COPD or asthma as well as the increased number of surgical operations lead to high demand for these gases. Furthermore, innovations in gas delivery systems and their applications in new areas like biotechnology or drug discovery further support the growth of this market.

"By application, therapeutics application segment is expected to have the largest market share in the medical gas and equipment market."

Based on application, the therapeutics application segment is expected to hold the largest market share in the medical gas and equipment market due to its vital role in treating various ailments. Essential for life support, anesthetics or anesthetic gases like oxygen, nitrous oxide as well as heliox (helium-oxygen mixture) are important medical gases of today's healthcare systems. For example, oxygen therapy is commonly used to treat chronic respiratory diseases among other emergency conditions. The increasing incidence rate of chronic illnesses coupled with the rising number of older people has necessitated a greater demand for therapeutic gases and related devices in homes. Moreover, availability and portability have been ensured by advancements made in gas delivery systems such as portable oxygen concentrators which have also contributed to an increase in this segment's share of the market.

"By end user, hospitals & clinics segment is expected to have the largest market share in the medical gas and equipment market."

Based on end user, the hospitals & clinics segment accounted for the largest market share of the medical gas and equipment market. They serve primarily as centers for surgeries, emergency treatments, and intensive care where medical gases such as oxygen, nitrous oxide and nitrogen, are mandatory for these services. This has created a huge demand for these gases in hospitals and clinics due to their high frequency of use in anesthesia, respiratory support or even other life-saving procedures. Additionally, the availability of more advanced healthcare infrastructure and rising chronic diseases today has necessitated prolonged oxygen therapy or other gas related treatments leading to a higher growth rate in this market.

"By region, North American region is expected to have the largest market share in the medical gas and equipment market."

North America to register for the highest share of the medical gas and equipment market during the forecast period due to several factors. The presence of advanced healthcare infrastructure, high health expenditure rates and the presence of a large elderly population drive the demand for medical gases and their related devices in this region. Chronic diseases such as asthma and chronic obstructive pulmonary disease (COPD) which require long-term oxygen therapy, are on the rise in this region thus fuelling industry growth. Furthermore, the existence of large pharmaceutical and biotech companies as well as a comprehensive government and regulatory support framework fuel the market growth in this region.

A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-20%, Director Level-35%, and Others-45%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10%.

Prominent players in the medical gas and equipment market are Air Liquide (France), Linde Plc (Germany), Taiyo Nippon Sanso Corporation (Japan), Air Products and Chemicals Inc. (US), Atlas Copco AB (Sweden), GCE Group (Sweden), Messer SE & Co. KGaA (Germany), SOL Spa (Italy), Rotarex (Europe), Norco Inc. (US), Genstar Technologies (US), Southern Gas Limited (India), Calox Inc. (US), Ellenbarrie Industrial Gases (India), Steelman Gases Pvt. Ltd. (India), Butler Gas Products Company (US), SCI Analytical (US), Amico Group of Companies (US), Oxygen & Argon Works Ltd. (Israel), AOPL (India), Apex Medical Gas Inc. (US), Chengdu Taiyo Industrial Gases Co., Ltd. (China), Carbide and Chemicals (India), Holston Gases (US), and MEC Medical Ltd. (UK).

Research Coverage:

The report analyzes the medical gas and equipment market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical gas and equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising demand for medical oxygen, increasing number of surgeries, growing elderly population, and rising demand for home healthcare), restraints (declining reimbursements for respiratory therapies, and global helium shortage), opportunities (expansion of healthcare industry, rising demand for pain management, and advancements in healthcare technology) and challenges (limited availability of medical gases, and high cost of medical gas equipment)
• Market Penetration: It includes extensive information on products offered by the major players in the global the medical gas and equipment market. The report includes various segments in type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical gas and equipment market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the medical gas and equipment market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical gas and equipment market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 MARKETS COVERED
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
  • 1.6.1 IMPACT OF GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW
• 4.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET
• 4.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX
• 4.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 4.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing demand for medical oxygen
    • 5.2.1.2 Growing number of surgeries
    • 5.2.1.3 Booming geriatric population
    • 5.2.1.4 Rising shift toward home healthcare services
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Declining reimbursements for respiratory therapies
    • 5.2.2.2 Global helium shortage
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expansion of healthcare industry
    • 5.2.3.2 Surge in demand for pain management solutions
    • 5.2.3.3 Growing advancements in healthcare technologies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited availability of medical gases
    • 5.2.4.2 High cost of medical gas equipment
• 5.3 INDUSTRY TRENDS
  • 5.3.1 POINT-OF-CARE DIAGNOSTICS AND HOME HEALTHCARE
  • 5.3.2 ADVANCEMENTS IN GAS DELIVERY SYSTEMS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 TECHNOLOGY ANALYSIS
  • 5.5.1 KEY TECHNOLOGIES
    • 5.5.1.1 IoT-based monitoring systems
  • 5.5.2 COMPLEMENTARY TECHNOLOGIES
    • 5.5.2.1 Digital alarm systems
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 REGULATORY LANDSCAPE
  • 5.7.1 REGULATORY ANALYSIS
  • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.8 PATENT ANALYSIS
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT DATA
  • 5.9.2 EXPORT DATA
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE OF MEDICAL GASES, BY KEY PLAYER
  • 5.10.2 AVERAGE SELLING PRICE TREND OF MEDICAL GAS AND EQUIPMENT
  • 5.10.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.11 KEY CONFERENCES AND EVENTS, 2024
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 UNMET NEEDS/END-USER EXPECTATIONS IN MEDICAL GAS AND EQUIPMENT MARKET
• 5.14 ADJACENT MARKET ANALYSIS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION
  • 5.16.2 IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE
  • 5.16.3 DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN
• 5.17 SUPPLY CHAIN ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
• 5.19 INVESTMENT AND FUNDING SCENARIO
• 5.20 REIMBURSEMENT SCENARIO
• 5.21 IMPACT OF GENERATIVE AI ON MEDICAL GAS AND EQUIPMENT MARKET

6 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 MEDICAL GASES
  • 6.2.1 PURE MEDICAL GASES
    • 6.2.1.1 Oxygen
      • 6.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth
    • 6.2.1.2 Carbon dioxide
      • 6.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth
    • 6.2.1.3 Nitrogen
      • 6.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market
    • 6.2.1.4 Nitrous oxide
      • 6.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth
    • 6.2.1.5 Medical air
      • 6.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market
    • 6.2.1.6 Other pure medical gases
  • 6.2.2 MEDICAL GAS MIXTURES
    • 6.2.2.1 Blood-gas mixtures
      • 6.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market
    • 6.2.2.2 Lung diffusion mixtures
      • 6.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth
    • 6.2.2.3 Nitrous oxide-oxygen mixtures
      • 6.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth
    • 6.2.2.4 Carbon dioxide-oxygen mixtures
      • 6.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market
    • 6.2.2.5 Laser gas mixtures
      • 6.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth
    • 6.2.2.6 Anaerobic gas mixtures
      • 6.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth
    • 6.2.2.7 Aerobic gas mixtures
      • 6.2.2.7.1 Booming geriatric population and rising pollution levels to drive market
    • 6.2.2.8 Helium-oxygen mixtures
      • 6.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth
    • 6.2.2.9 Other medical gas mixtures
• 6.3 MEDICAL GAS EQUIPMENT
  • 6.3.1 EQUIPMENT ACCESSORIES
    • 6.3.1.1 Vacuum systems
      • 6.3.1.1.1 Growing focus on infection control and complex surgical therapies to propel market
    • 6.3.1.2 Manifolds
      • 6.3.1.2.1 Increasing need for critical care services to encourage growth
    • 6.3.1.3 Regulators
      • 6.3.1.3.1 Rising focus on treatment efficacy and patient safety to augment growth
    • 6.3.1.4 Flowmeters
      • 6.3.1.4.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market
    • 6.3.1.5 Hoses
      • 6.3.1.5.1 Expanding range of medical equipment requiring gas supply to support market
    • 6.3.1.6 Valves with integrated pressure regulators
      • 6.3.1.6.1 Rising focus on improved patient care and streamlined operations to favor growth
    • 6.3.1.7 Monitoring systems
      • 6.3.1.7.1 Need for safe and effective delivery of medical gases to aid growth
    • 6.3.1.8 Medical air compressors
      • 6.3.1.8.1 Increasing demand for advanced healthcare services to augment growth
    • 6.3.1.9 Other equipment accessories
  • 6.3.2 GAS DELIVERY SYSTEMS
    • 6.3.2.1 Rising focus on patient stability and recovery to promote growth
  • 6.3.3 CRYOGENIC PRODUCTS
    • 6.3.3.1 Growing applications in modern healthcare and life sciences to fuel market

7 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 THERAPEUTIC APPLICATIONS
  • 7.2.1 RESPIRATORY THERAPIES
    • 7.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market
  • 7.2.2 CARDIOVASCULAR THERAPIES
    • 7.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth
  • 7.2.3 ANESTHESIA DELIVERY
    • 7.2.3.1 Growing incidence of age-related health conditions to fuel market
  • 7.2.4 CRYOSURGERY APPLICATIONS
    • 7.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth
  • 7.2.5 OTHER THERAPEUTIC APPLICATIONS
• 7.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS
  • 7.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH
• 7.4 DIAGNOSTIC APPLICATIONS
  • 7.4.1 MEDICAL IMAGING
    • 7.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market
  • 7.4.2 GENERAL LABORATORY APPLICATIONS
    • 7.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market
• 7.5 OTHER APPLICATIONS

8 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & CLINICS
  • 8.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH
• 8.3 HOME HEALTHCARE
  • 8.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET
• 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH
• 8.5 ACADEMIC & RESEARCH INSTITUTIONS
  • 8.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET
• 8.6 OTHER END USERS

9 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Presence of key players to sustain growth
  • 9.2.3 CANADA
    • 9.2.3.1 Stringent regulatory compliances to favor market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Growing adoption of advanced healthcare technologies to fuel market
  • 9.3.3 UK
    • 9.3.3.1 Growing aging population to drive market
  • 9.3.4 FRANCE
    • 9.3.4.1 Well-established healthcare system to support growth
  • 9.3.5 SPAIN
    • 9.3.5.1 High burden of chronic diseases to augment growth
  • 9.3.6 ITALY
    • 9.3.6.1 Rising demand for therapeutic gases to aid growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Dominant elderly population to propel market
  • 9.4.3 CHINA
    • 9.4.3.1 Strong public healthcare infrastructure to stimulate growth
  • 9.4.4 INDIA
    • 9.4.4.1 Growing incidence of cardiovascular diseases to spur growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Robust Medicare program to facilitate growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing healthcare spending to contribute to market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Expanding pharmaceutical industry to propel market
  • 9.5.4 ARGENTINA
    • 9.5.4.1 Rising modernization of healthcare systems to encourage growth
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO AUGMENT GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Type footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 BRAND/PRODUCT COMPARISON
• 10.8 R&D EXPENDITURE OF KEY PLAYERS
• 10.9 COMPANY VALUATION AND FINANCIAL METRICS
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 DEALS
  • 10.10.2 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 AIR LIQUIDE
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 LINDE PLC
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 TAIYO NIPPON SANSO CORPORATION
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 AIR PRODUCTS AND CHEMICALS, INC.
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 MnM view
      • 11.1.4.3.1 Right to win
      • 11.1.4.3.2 Strategic choices
      • 11.1.4.3.3 Weaknesses and competitive threats
  • 11.1.5 ATLAS COPCO AB
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 GCE GROUP
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
  • 11.1.7 MESSER SE & CO. KGAA
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 SOL SPA
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 ROTAREX
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 NORCO INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 GENSTAR TECHNOLOGIES
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 SOUTHERN GAS LIMITED
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 CALOX INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 ELLENBARRIE INDUSTRIAL GASES
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 STEELMAN GASES PVT. LTD.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 BUTLER GAS PRODUCTS COMPANY
  • 11.2.2 SCI ANALYTICAL
  • 11.2.3 AMICO GROUP OF COMPANIES
  • 11.2.4 OXYGEN & ARGON WORKS LTD
  • 11.2.5 AOPL ENERGY
  • 11.2.6 APEX MEDICAL GAS INC.
  • 11.2.7 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
  • 11.2.8 CARBIDE AND CHEMICALS
  • 11.2.9 HOLSTON GASES
  • 11.2.10 MEC MEDICAL LTD.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS